UBS Group
TMPM

UBS Group’s Turmeric Acquisition Corp. Class A Ordinary Shares TMPM Stock Holding History

UBS Group’s Portfolio TMPM Stock Details TMPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,435
Closed -$14K – 11953
2022
Q3 		$14K Buy
1,435
+10
+0.7% +$100 ﹤0.01% 7990
2022
Q2 		$14K Sell
1,425
-337
-19% -$3.33K ﹤0.01% 7471
2022
Q1 		$17K Buy
1,762
+338
+24% +$3.32K ﹤0.01% 7716
2021
Q4 		$14K Sell
1,424
-899
-39% -$8.81K ﹤0.01% 8402
2021
Q3 		$23K Buy
2,323
+999
+75% +$9.75K ﹤0.01% 7042
2021
Q2 		$13K Buy
1,324
+349
+36% +$3.43K ﹤0.01% 7832
2021
Q1 		$10K Buy
+975
New +$9.94K ﹤0.01% 7965

UBS Group's TMPM Position: Q4 2022 in Review

UBS Group sold out of Turmeric Acquisition Corp. Class A Ordinary Shares (TMPM) in Q4 2022, closing a stake of 1,435 shares — an estimated $14K sold.

UBS Group first reported a position in TMPM in Q1 2021 and held it in 7 quarters. The position peaked at $23K in Q3 2021. 0 funds tracked by Wall St. Rank hold TMPM as of Q4 2022.

  • UBS Group reported no remaining Turmeric Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 1,435 Turmeric Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $14K.
  • UBS Group first reported a position in Turmeric Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
  • UBS Group's Turmeric Acquisition Corp. Class A Ordinary Shares position peaked at $23K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Turmeric Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.